Savara Inc insider trading
Every open-market purchase and sale by Savara Inc's officers, directors and largest shareholders since November 4, 2021, and what the share price did next.
| Date | Insider | Trade | Shares | Price | Value | 1M after | 3M after | 6M after |
|---|
Does following Savara Inc’s insiders pay?
From March 15, 2012 to June 22, 2026, 14 insiders reported 54 open-market purchases and 9 sales not made under a pre-set plan in Savara Inc. Twelve months after each purchase was reported, the shares were +31.4% against the S&P 500 on average (median +77.4%), over 8 purchases with a full year of prices; 63% beat the index. After sales, the shares moved −84.5% against the index over 12 months (a negative figure means selling was the right call). That rests on fewer than 20 purchases, too few to read much into. Buying each purchase the day after it was reported, an equal amount each, held 12 months or until that insider reported a sale, would have turned $10,000 on June 12, 2017 into $3,540 by November 2, 2026, −10.5% a year. It held shares 27% of the time; the S&P 500 on those same days, with Treasury bills otherwise, made $17,043 (+5.9% a year), and held throughout $36,029 (+14.7%).
| Insider | Role | Purchases | 12 months after their purchases | Beat the S&P 500 | Sales | 12 months after their sales | Latest report |
|---|---|---|---|---|---|---|---|
| Ramsay David A | Director | 30 | +77.4% (1) | 100% | 1 | — | December 19, 2025 |
| Pauls Matthew | CHIEF EXECUTIVE OFFICER | 7 | — | — | 2 | — | December 16, 2024 |
| Lowrance David L | Chief Financial Officer | 1 | — | — | 3 | — | June 22, 2026 |
| Mccracken Joseph S | Director | 4 | +77.4% (1) | 100% | 0 | — | June 2, 2025 |
| Hawkins Richard J | Director | 1 | — | — | 2 | −84.5% (1) | June 23, 2025 |
| Pikover Yuri | Director | 3 | +19.3% (3) | 33% | 0 | — | April 2, 2018 |
| Neville Robert N | Chief Executive Officer | 2 | −19.2% (2) | 50% | 0 | — | December 21, 2018 |
| Chowdhury Badrul A. | CHIEF MEDICAL OFFICER | 1 | — | — | 0 | — | December 9, 2021 |
| Culley Brian M | CEO and Director | 1 | — | — | 0 | — | March 15, 2012 |
| Elam Nevan C | Director | 0 | — | — | 1 | — | December 29, 2023 |
| Jouhikainen Jaakko Taneli | See Remarks | 1 | +77.4% (1) | 100% | 0 | — | June 9, 2017 |
| Pratt Raymond Dennis | Chief Medical Officer | 1 | — | — | 0 | — | June 27, 2023 |
| Roberts Brandi | Chief Financial Officer & SVP | 1 | — | — | 0 | — | March 30, 2015 |
| Sandell Scott D and related entities | 10% owner | 1 | — | — | 0 | — | July 19, 2023 |
When several insiders traded Savara Inc
Months when 2 or more insiders became net buyers, or 3 or more net sellers, of Savara Inc in reports dated in the 91 days before the month end, and how the stock did against the S&P 500 from that month end. After the 1 buying crowd with six months of prices, it averaged +140.9% against the index. One company's history is too short to judge by; the test across every company is the better guide.
| Month | Crowd | 3 months on, vs S&P 500 | 6 months | 12 months |
|---|---|---|---|---|
| June 30, 2017 | 5 buying | +54.6% | +140.9% | +86.3% |